Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -758.99% | 5.90% | 6.69% | -241.64% | 126.31% |
| Total Depreciation and Amortization | -4.00% | -90.38% | 1.17% | 0.39% | 6.22% |
| Total Amortization of Deferred Charges | 15.66% | -22.60% | -2.58% | 18.17% | 20.28% |
| Total Other Non-Cash Items | 39,283.91% | 64.92% | -143.36% | 107.52% | -175.10% |
| Change in Net Operating Assets | 180.70% | -59.27% | 73.39% | 1,292.31% | 108.32% |
| Cash from Operations | 23.37% | -49.14% | 12.36% | 13.04% | 28.79% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 4.21% |
| Total Debt Issued | -21.24% | 36.49% | 13.65% | -45.07% | -8.61% |
| Total Debt Repaid | -11.89% | -10.64% | 12.09% | 22.82% | 11.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -32.03% | 47.77% | 30.29% | -53.70% | -7.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.74% | 12.79% | 111.39% | -215.80% | 388.50% |